Millions of Americans can now look forward to a better time traveling, with the US Food and Drug Administration (FDA) ...

The FDA approved Vanda’s drug Nereus to prevent motion-induced vomiting, opening a potential path into treating nausea linked ...

Vanda also sells sleep disorder drug Hetlioz, which reached the market in 2014, and relapsing multiple sclerosis treatment ...

Jefferies analysts envision a steady launch curve that could ultimately drive meaningful sales from people who are ...

The scopolamine skin patch (Transderm Scōp), approved in 1979, was the last drug sanctioned by the FDA to prevent motion ...

Vanda Pharmaceuticals has received FDA approval for Nereus (tradipitant), an oral NK-1 receptor antagonist developed to prevent motion-induced vomiting. The approval makes Nereus the first new ...

Vanda Pharmaceuticals said on Tuesday its drug for the prevention of motion-induced vomiting was approved by the U.S. health ...

Vanda Pharmaceuticals received FDA approval for Nereus for motion sickness, and its shares offer upside potential into 2026 ...

Motion sickness is something that has troubled most of us. While some may get over the feeling with time, others may continue to battle the woes of motion sickness throughout their life. "Motion ...

Rick Steves' travel writer, Cameron Hewitt, knows that he should always bring these inexpensive (and tiny) tool when ...

Motion sickness is an unpleasant sensation commonly seen in some vulnerable individuals when they are subjected to unnatural motion. All persons can develop motion sickness if given the right stimulus ...